Abundance of clinical Material in India is promising and inviting international clinical Trials, especially Phase III. We need to prepare our centres with full infrastructure and trained personnel to be ready to take up such Phase III Clinical Trials.
The boom in Biotechnology, and Nanotechnology and Stem Cell Culture has opened a wide scope of research especially in Vascular Biology. National Health Department and National Directorates for Biotechnology, scientific research give full encouragement for Research in Stem Cell Mediated Therapeutics. VSI sees a golden opportunity for its application in clinical research with autologous stem cell in Acutely Ischaemic Limbs.